Trial intelligence / Profile preview

Teicoplanin pharmacokinetics in adults with haematological malignancy

2013-004535-72Phase 4Completed

Sponsor
Tallaght University Hospital
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of teicoplanin in Gram-positive bacterial infection, sponsored by Tallaght University Hospital. Primary endpoint: Pharmacokinetic parameters of teicoplanin. Started Nov 2013; status: completed.

02

Drugs

teicoplanin
03

Conditions

Gram-positive bacterial infection

Beyond the preview

Go deeper on 2013-004535-72.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004535-72.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call